Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of

Athina Savva1, Matthijs C Brouwer2, Thierry Roger1

  • 1Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-10111 Lausanne, Switzerland;

Insights

High-expression alleles of the macrophage migration inhibitory factor (MIF) gene are linked to worse outcomes and death in pneumococcal meningitis. MIF may be a therapeutic target for this critical bacterial infection.

Area of Science:

  • Immunogenetics
  • Infectious Diseases
  • Molecular Biology

Background:

  • Pneumococcal meningitis is a severe bacterial infection.
  • Cytokines, including macrophage migration inhibitory factor (MIF), are implicated in disease pathogenesis.
  • Genetic variations in MIF may influence susceptibility and severity.

Purpose of the Study:

  • To investigate the association between functional polymorphisms in the MIF gene and the clinical outcomes of pneumococcal meningitis.
  • To explore the role of MIF in the inflammatory response and its potential as a therapeutic target.

Main Methods:

  • Genotyping of two functional MIF promoter polymorphisms (-794 CATT5-8 and -173 G/C) in 405 patients and 329 controls.
  • Analysis of MIF levels in cerebrospinal fluid.
  • In vitro studies on MIF production by Streptococcus pneumoniae.
  • Evaluation of anti-MIF antibody treatment in a mouse model.

Main Results:

  • Carriage of high-expression MIF alleles (CATT7 and -173 C) was significantly associated with unfavorable outcomes and increased mortality.
  • Shock and CATT7 allele carriage were independent predictors of mortality.
  • Elevated MIF levels in cerebrospinal fluid correlated with systemic complications and death.
  • Streptococcus pneumoniae up-regulated MIF production, and anti-MIF antibodies improved survival in mice.

Conclusions:

  • High-expression MIF alleles serve as a genetic marker for pneumococcal meningitis morbidity and mortality.
  • MIF plays a critical role in the pathogenesis of pneumococcal meningitis.
  • Targeting MIF with immunomodulatory therapy may offer a novel treatment strategy.

Related Concept Videos